Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Solomon

Showing results (1241-1250 of 1,388) with videos related to

Pageof 139
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small-cell lung cancerJ-C Soria, S N Ho, M Varella-Garcia, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
FLAMeS: A Robust Deep Learning Model for Automated Multiple Sclerosis Lesion SegmentationEmma Dereskewicz, Francesco La Rosa, Jonadab Dos Santos Silva, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 12, 2026
Wound Healing and Angiogenic Profiling of Dermal Endothelial Cells Isolated From People With Type 2 DiabetesJames Shadiow, Corey E Mazo, Pallavi Varshney, et al.
Iscience|January 14, 2026
Neutrophil degranulation in the lung microenvironment linked to idiopathic pulmonary fibrosis severity and survivalScott M Matson, Linh T Ngo, Yui Sugawara, et al.
Preventive Medicine|November 28, 2002
Evaluation of a community breast screening promotion programJohn K Worden, Ruth M Mickey, Pamela M Vacek, et al.
The Lancet. Oncology|November 1, 2019
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trialAlice T Shaw, Benjamin J Solomon, Rita Chiari, et al.
Future Oncology (London, England)|November 5, 2020
Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated <i>RET</i> positive non-small-cell lung cancerBenjamin J Solomon, Cai Cun Zhou, Alexander Drilon, et al.
Pathology|March 18, 2025
Molecular testing of lung cancer in Australia: consensus best practice recommendations from the Royal College of Pathologists of Australasia in collaboration with the Thoracic Oncology Group of AustralasiaWendy A Cooper, Benhur Amanuel, Caroline Cooper, et al.
Annals of Surgery|June 6, 2024
Infrapopliteal Endovascular Interventions for Claudication Are Associated with Poor Long-Term Outcomes in Medicare-Matched Registry PatientsSanuja Bose, Katherine M McDermott, Chen Dun, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 26, 2025
Genetically-Programmed Hypervesiculation of Lactiplantibacillus Plantarum Increases Production of Bacterial Extracellular Vesicles with Therapeutic Efficacy in a Preclinical Inflammatory Bowel Disease ModelNicholas H Pirolli, Daniel Levy, Alyssa Schledwitz, et al.
Pageof 139

Showing results (1241-1250 of 1,388) with videos related to

Sort By:
Pageof 139
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small-cell lung cancerJ-C Soria, S N Ho, M Varella-Garcia, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
FLAMeS: A Robust Deep Learning Model for Automated Multiple Sclerosis Lesion SegmentationEmma Dereskewicz, Francesco La Rosa, Jonadab Dos Santos Silva, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 12, 2026
Wound Healing and Angiogenic Profiling of Dermal Endothelial Cells Isolated From People With Type 2 DiabetesJames Shadiow, Corey E Mazo, Pallavi Varshney, et al.
Iscience|January 14, 2026
Neutrophil degranulation in the lung microenvironment linked to idiopathic pulmonary fibrosis severity and survivalScott M Matson, Linh T Ngo, Yui Sugawara, et al.
Preventive Medicine|November 28, 2002
Evaluation of a community breast screening promotion programJohn K Worden, Ruth M Mickey, Pamela M Vacek, et al.
The Lancet. Oncology|November 1, 2019
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trialAlice T Shaw, Benjamin J Solomon, Rita Chiari, et al.
Future Oncology (London, England)|November 5, 2020
Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated <i>RET</i> positive non-small-cell lung cancerBenjamin J Solomon, Cai Cun Zhou, Alexander Drilon, et al.
Pathology|March 18, 2025
Molecular testing of lung cancer in Australia: consensus best practice recommendations from the Royal College of Pathologists of Australasia in collaboration with the Thoracic Oncology Group of AustralasiaWendy A Cooper, Benhur Amanuel, Caroline Cooper, et al.
Annals of Surgery|June 6, 2024
Infrapopliteal Endovascular Interventions for Claudication Are Associated with Poor Long-Term Outcomes in Medicare-Matched Registry PatientsSanuja Bose, Katherine M McDermott, Chen Dun, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 26, 2025
Genetically-Programmed Hypervesiculation of Lactiplantibacillus Plantarum Increases Production of Bacterial Extracellular Vesicles with Therapeutic Efficacy in a Preclinical Inflammatory Bowel Disease ModelNicholas H Pirolli, Daniel Levy, Alyssa Schledwitz, et al.
Pageof 139